BOUSSIGNAC CPAP SYSTEM REF 5562.513 5562.513

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2012-04-05 for BOUSSIGNAC CPAP SYSTEM REF 5562.513 5562.513 manufactured by Vygon.

Event Text Entries

[2623381] An (b)(6) emergency medical services team was called to a nursing home to assist a (b)(6) male. He was found to be in cute congestive heart failure; rhonchi in all lung fields, with hypoxia. Spo2 82% on 6lpm by nasal cannula was attempted to be treated with a vygon boussignac cpap system lot 11a11. When removed from packaging, the device was found to be broken at the point that the oxygen supply line contacts the delivery port and was thus unusable. An alternative cpap system was rapidly obtained and no adverse pt outcome occurred. A second vygon boussignac cpap system from the same lot was obtained to replace the faulty system and found to have the same defect.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5024964
MDR Report Key2532160
Date Received2012-04-05
Date of Report2012-04-05
Date of Event2012-04-02
Date Added to Maude2012-04-13
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameBOUSSIGNAC CPAP SYSTEM
Generic NameCPAP
Product CodeBYE
Date Received2012-04-05
Model NumberREF 5562.513
Catalog Number5562.513
Lot Number11A11
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Sequence No1
Device Event Key0
ManufacturerVYGON


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2012-04-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.